Pourquoi les femmes diffèrent-elles leur recours aux soins relativement à un cancer du sein localement avancé
Abstract
Le cancer du sein localement avancé (CSLA) est impliqué dans 10–30 % de tous les nouveaux diagnostics de cancer du sein primaire. Pour des raisons encore mal comprises, 20–30 % des femmes atteintes du cancer du sein (quelque que soit le stade) attendent huit semaines ou plus entre le moment où elles remarquent un ou plusieurs symptôme(s) mammaire(s) et celui où elles consultent un prestataire de soins de santé. Il est essentiel de bien comprendre les mécanismes sous-tendant les comportements liés à l’autoévaluation de la santé et au recours aux soins de santé, particulièrement chez les femmes atteintes d’un CSLA. Cette étude avait pour but de mener une exploration qualitative de l’expérience cognitive, émotionnelle et contextuelle des femmes atteintes du cancer du sein localement avancé durant la période située entre la découverte d’un symptôme et le recours à des soins de santé. Des entrevues qualitatives détaillées, une analyse du contenu et une analyse globale ont révélé que les participantes retardaient leur recours aux soins parce qu’elles ne se considéraient pas à risque de développer un cancer du sein, avaient un symptôme autre qu’une masse ce qui les amenait à minimiser la gravité du symptôme ou à l’attribuer, à tort, à une autre cause parce qu’elles avaient déjà eu une tumeur bénigne et/ou parce qu’elles éprouvaient durant ce même temps des événements de la vie stressants. Ces participantes en venaient à consulter si elles avaient déjà pris rendez-vous avec un professionnel de la santé pour une autre raison, si elles jugeaient que le symptôme empirait avec le temps ou si un être cher les avait encouragées à consulter. On discute des implications de l’étude pour la promotion de la santé et l’éducation à la santé auprès des femmes ayant des antécédents de maladie bénigne du sein et auprès du grand public.
References
Absetz, P., Aro, A.R., & Sutton, S.R. (2003). Experience with breast
cancer, pre-screening perceived Absetz, P., Aro, A.R., & Sutton,
S.R. (2003). Experience with breast cancer, pre-screening
perceived susceptibility and the psychological impact of
screening. Psycho-Oncology, 12(4), 305–318.
Andrykowski, M.A., Carpenter, J.S., Studts, J.L., Cordova, M.J.,
Cunningham, L.C., Beacham, A., et al. (2002). Psychological
impact of benign breast biopsy: A longitudinal, comparative study.
Health Psychology, 21(5), 485–494.
Andrykowski, M., Carpenter, J.S., Studts, J.L., Cordova, M.J.
Cunningham, L., Mager, W., et al. (2001) Adherence to
recommendations for clinical follow-up after benign breast biopsy.
Breast Cancer Research and Treatment, 69(2), 165–178.
Gelert Chaussures Rocky Gelert Gelert Chaussures Rando Rocky Rando Chaussures Rocky Chaussures Gelert Rando Rando Rocky d4B4xqBish, A., Ramirez, A., Burgess, C., & Hunter, M. (2005).
Understanding why women delay in seeking help for breast cancer
symptoms. Journal of Psychosomatic Research, 58, 321–326.
Burgess, C.C., Hunter, M.S., & Ramirez, A.J. (2001). A qualitative
study of delay among women reporting symptoms of breast
cancer. British Journal of General Practice, 54(473), 967–971.
Burgess, C.C., Potts, H.W.W., Hamed, H., Bish, A., Hunter, M.S.,
Richards, M.A. et al. (2006). Why do older women delay
presentation with breast cancer symptoms? Psycho-Oncology, 15,
–968.
Burgess, C.C., Ramirez, A.J., Richards, M.A., & Love, S.B. (1998).
Who and what influences delayed presentation in breast cancer?
British Journal of Cancer, 77(8), 1343–1348.
Caplan, L., & Helzlsouer, K. (1992). Delay in breast cancer: A review
of the literature. Public Health Review, 20, 187–214.
Cresswell, J.W. (2003). Research design: Qualitative, quantitative,
and mixed methods approaches (2nd ed.). Thousand Oaks: Sage
Publications.
Cunningham, L.C., Andrykowski, M.A., Wilson, J.F., McGrath, P.C.,
Sloan, D.A., & Kenady, D.E. (1998). Physical symptoms, distress,
Ld91 Flex 3 Flex Skechers Skechers Ez 3 Ez Skechers Ld91 Ez and breast cancer risk perceptions in women with benign breast
problems. Health Psychology, 17(4), 371–375.
Facione, N.C., & Facione, P.A. (2006). The cognitive structuring of
patient delay in breast cancer. Social Science and Medicine, 63,
–3149.
Facione, N. (2002). Perceived risk of breast cancer: Influence of
heuristic thinking. Cancer Practice, 10(5), 256–261.
Facione, N.C., Miaskowski, C.,.Dodd, M.J., & Paul, S.M. (2002). The
self-reported likelihood of patient delay in breast cancer: New
thoughts for early detection. Preventive Medicine, 34(4), 397–407.
Facione, N.C., & Giancarlo, C.A. (1998). Narratives of breast
symptom discovery and cancer diagnosis: Psychologic risk for
advanced cancer at diagnosis. Cancer Nursing, 21(6), 430–440.
Fitzgerald, B., Clemons, M., & Dent, R. (2006). A clinic for patients
with locally advanced breast cancer: An integrated, patient-centred
program. Oncology Exchange, 5(1), 29–34.
Grunfeld, E.A., Ramirez, A.J., Hunter, M.S., & Richards, M.A.
(2002). Women’s knowledge and beliefs regarding breast cancer.
British Journal of Cancer, 86(9), 1373–1378.
Guba, E.G., & Lincoln, Y.S. (1994). Competing paradigms in qualitative
research. In N.K. Denzin and Y.S. Lincoln (Eds.), Handbook of
Qualitative Research. Thousand Oaks, CA: Sage Publications.
Guest, G., Bunce, A., & Johnson, L. (2006). How many interviews are
enough? An experiment with data saturation and variability. Field
Methods, 18(1), 59–82.
Harirchi, I., Chaemmaghami, F., Karbakhsh, M., Moghimi, R., &
Mazaherie, H. (2005). Patient delay in women presenting with
Step Skechers Lite Ladies Go Trainers UxHwnq15Ld91 3 Skechers Ld91 Ez Skechers Ez Flex Flex Skechers 3 Ez advanced breast cancer: An Iranian study. Public Health 119,
–891.
Huang, E.H., Tucker, S., Strom, E., McNeese, M., Kuerer, H.,
Hortobagyi, G., et al. (2003). Radiation treatment improves local
regional control and survival in patients with locally advanced
breast cancer treated with neoadjuvant chemotherapy and
mastectomy. International Journal of Radiation Oncology Biol.
Phys, Suppl. 2, S238.
Ladies 2 Flyte Wings Trainers Salomon YgBPwPKatapodi, M., Lee, K.A., Facione, N.C., & Dodd, M.J. (2004).
Predictors of perceived breast cancer risk and the relation between
perceived risk and breast cancer screening: A meta-analytic
review. Preventive Medicine, 38(4), 388–402.
Kaufman, M., Hortobagyi, G.N., Goldhirsch, A., Scholl, S., Makris,
A., Valagussa, P., et al. (2006). Recommendations from an
Ld91 Skechers 3 3 Skechers Ez Ld91 Flex Ez Skechers Ez Flex international expert panel on the use of neoadjuvant (primary)
systemic treatment of operable breast cancer: An update. Journal
of Clinical Oncology, 24(19), 3221.
Lauver, D., Coyle, M., & Panchmatia, B. (1995). Women’s reasons
for and barriers to seeking care for breast cancer symptoms.
Women’s Health Issues, 5(1), 27–35.
McQueen, A., Vernon, S.W., Meissner, H.I., & Rakowski, W. (2008).
Risk perceptions and worry about cancer: Does gender make a
difference? Journal of Health Communication, 13(1), 56–79.
Meechan, G., Collins, J., & Petrie, K.J. (2003). The relationship of
symptoms and psychological factors to delay in seeking medical
care for breast symptoms. Preventive Medicine, 36(3), 374–378.
Nosarti, C., Crayford, T., Roberts, J.V., Elias, E., McKenzie, K., &
David, A.S. (2000). Delay in presentation of symptomatic referrals
to breast clinic: Patient and system factors. British Journal of
Cancer, 82(3), 742–748.
Ez Flex Flex Ld91 Ez Skechers Skechers 3 Ld91 3 Skechers Ez Olivotto, I.A., Bancej, C., Goel, V., Snider, J., McAuley, R.G., Irvine,
B., et al. (2001). Waiting times from abnormal breast screen to
diagnosis in seven Canadian provinces. Canadian Medical
Association Journal, 165, 277–283.
Patton, M.A. (2001). Qualitative research & evaluation methods
(3rd ed.). Thousand Oaks, CA: Sage Publications.
Ramirez, A.J., Westcombe, A.M., Burgess, C.C., Sutton, S.,
Skechers 3 Flex Ld91 Ez Flex Ez 3 Skechers Ez Ld91 Skechers Littlejohns, P., & Richards, M.A. (1999). Factors predicting
delayed presentation of symptomatic breast cancer: A systematic
review. The Lancet, 353, 1127–1131.
Astro adidas Tennis Homme Goletto Turf nnOvqZgRichards, M.A., Westcombe, A.M., Love, S.B., Littlejohns, P., &
Ramirez, A.J. (1999a). Influence of delay on survival in patients
with breast cancer: A systematic review. The Lancet, 353,
–1126.
Richards, M.A., Smith, P., Ramirez, A.J., Fentiman, I.S., & Rubens,
R.D. (1999b). The influence of survival of delay in the
presentation and treatment of symptomatic breast cancer. British
Journal of Cancer, 79(5/6), 858–864.
Sant, M., Allemani, C., Capocaccia, R., Hakulinen, T., Aareleid, T.,
3 Flex Flex Ld91 Skechers Skechers Ez Ld91 Skechers 3 Ez Ez Coebergh, J.W., et al. (2003). EUROCARE Working Group. Stage
at diagnosis is a key explanation of differences in breast cancer
survival across Europe. International Journal of Cancer, 106(3),
–22.
Singletary, S.E., Allred, C., Ashley, P., Bassett, L.W., Berry, D.,
Skechers Ez Ez 3 Ez Flex 3 Ld91 Ld91 Skechers Skechers Flex Bland, K.I., et al. (2002). Revision of the American Joint
Committee on cancer staging system for breast cancer. Journal of
Clinical Oncology, 20, 328–3636.
Smith, L.K., Pope, C., & Botha, J.L. (2005). Patients’ help-seeking
experiences and delay in cancer presentation: A qualitative
synthesis. The Lancet, 366, 825–831.
Flex Ez Ez 3 Ld91 Ez Skechers Skechers Ld91 3 Flex Skechers
Refbacks
- Ld91 Skechers Skechers 3 Ez 3 Ld91 Flex Ez Flex Ez Skechers There are currently no refbacks.
Ld91 Skechers Skechers Ez Flex Ez 3 Flex Skechers Ez Ld91 3